CPEG
GCEP

Colleagues, please take note of the following invitation:

To The Secretaries of Pediatric Endocrine Societies
Please include the following announcement in your Newsletter of your society. Having obtained interesting preliminary results in our worldwide survey on the revalence of malignancy in patients with congenital IGF-I deficiency, we are enlarging the scope of our study by including patients with GHRH-R defects, IGHD, IGF-I-R defects and also patients with PROP-1, Pit-1, HesX-1 mutation (and certainly new patients with LS)
Should you know and/or follow patients with the above diagnoses please contact us to the following addresses and we shall send you further details and a simple questionnaire. Looking forward for your collaboration,
Sincerely,
Zvi Laron,MD
Endocrinology and Diabetes Research Unit
Schneider Childrens' Medical Center
14 Kaplan st.
Petah-Tikva 49202
Israel
Tel: 972-2-9253610-1
Fax: 972-3-9222996
email: laronz [nospam "AT"] clalit.org.il
or to:
Orit Shevah, res.ass.
shev72 [nospam "AT"] bezeqit.net

Note that I have altered the email addresses so that it cannot be easily lifted by Internet bottom-feeders trawling for addresses. Please make manual adjustments to the address if you will be contacting Dr. Laron.